Houston, Texas
United States
6
2013-09-05
5
2014-02-11
These are the the leading inventors for applications assigned to ONCOLIX, INC.:
ONCOLIX, INC. based in Houston, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Use of Prolactin Receptor Antagonist and Chemotherapeutic Drug for Treating Ovarian Cancer
#2 | 2011-03-17 ✅ Patent 8,648,046 granted on 2014-02-11Compositions and methods for visualizing and eliminating cancer stem cells
#3 | 2010-08-26 ✅ Patent 8,754,035 granted on 2014-06-17Compositions and methods for visualizing and eliminating cancer stem cells
#4 | 2009-12-15 ✅ Patent 7,632,809 granted on 2009-12-15Multimeric ligands with enhanced stability
#5 | 2009-04-02 ✅ Patent 8,304,381 granted on 2012-11-06Human prolactin antagonist-angiogenesis inhibitor fusion proteins
#6 | 2005-12-08 ✅ Patent 8,754,031 granted on 2014-06-17Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
37831 ⎘